Tevogen Bio Holdings Inc.TVGNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-46.84%
↓ 78% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-26.33%
Historical baseline
PeriodValue
2024-46.84%
20235.60%
2022-64.09%
20210.00%